Form D · Biotechnology
AvidBiotics Corp.
South San Francisco, CA · CIK 0001324632
Offering snapshot reported Sep 18, 2014 · SEC filing
- Reported sold
- $854K Offering amount: $15M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 3, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2014 | Initial | $854,128 | No comparison | 12 | SEC filing |
| Aug 30, 2012 | Amendment | $2,087,670 | $247,497vs Jul 27, 2012 | 29 | SEC filing |
| Jul 27, 2012 | Initial | $1,840,173 | No comparison | 15 | SEC filing |
| Oct 22, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 19, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224988
Source: Form D, filed Sep 18, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Cameron | Director |
| Steve Creager | Executive |
| James L Knighton | Director, Executive |
| David Martin | Director |
| Jeffery Miller | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Kimball Way
South San Francisco, CA, 94080
South San Francisco, CA, 94080